Observational study reveals dominant uptake of active surveillance in low-risk prostate cancer, highlighting a global benchmark for favorable-risk disease management.
Active surveillance has become the dominant management for low-risk prostate cancer among men in Sweden, with the highest rates yet reported and almost complete uptake for very-low-risk cancer. These data should serve as a benchmark to compare the use of active surveillance for favorable-risk disease around the world.
No takes yet. Share an insight, caveat, or question.
Loeb et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: